Stock screener

RXST

Conviction 0HealthcareScan · Thu, Jun 25, 2026
RXST$5.12-3.67%
ResistanceSupportVol 14
63 bars
Vol MA14 952.17K
Mar 26Apr 14May 1May 19Jun 8Jun 25
RxSight, Inc.OPHTHALMIC GOODSwww.rxsight.com
Price5.12
Change-3.67%
Gap-0.47%
Rel volume0.69×
Avg volume1.02M
Avg $ vol5.09M
SMA 204.97
SMA 505.94
SMA 2008.29
Price vs 50-13.89%
Price vs 200-38.26%
MA stackbearish
50/200 cross
Supertrenddown · 5.52
RSI (14)47
MACD hist0.11
MACD crossbull · 5d
Stoch %K / %D64 / 80
ADX (14)29
+DI / −DI23 / 25
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.11%
ADR %5.92%
52w high13.23
52w low4.59
From 52w high-61.34%
Above 52w low+11.44%
New 52w highNo
SqueezeOff
Bollinger width21.25%
%B0.64
Donchian pos52.48%
Donchian high5.69
Donchian low4.48
AVWAP (52w high)8.33
vs AVWAP high-38.59%
AVWAP (52w low)4.86
vs AVWAP low+5.25%
OBV trendDown
Chaikin MF (20)-0.15
Today vs 20d0.69×
Avg vol (14d)952.17K
Avg vol (20d)1.02M
Avg $ vol (20d)5.09M
Market cap211.74M
RS 3m (vs SPY)-27.43%
RS 6m (vs SPY)-63.60%
RS line new highNo
Trend template0/8
Technical rank15.0
1 week+11.44%
1 month-14.61%
3 months-22.38%
6 months-58.18%
1 year-62.66%
YTD-50.72%
P/E-5.44
P/B0.79
P/S1.57
P/FCF-10.95
EPS-0.9500
Div yield
ROE-14.57%
ROA-12.81%
Debt/Eq0.00
Current10.20
EV/EBITDA-4.32
Gross margin76.60%
Net margin-28.96%
Rev growth-3.89%
EPS growth-41.85%
Price target9.67
Target upside89.05%
Analyst ratingHold
Institutional99.99%
Ent. value194.17M
Revenue30.89M
Net income-15.88M
Gross profit23.5M
Free cash flow-19.34M
IndustryOPHTHALMIC GOODS
ExchangeNasdaq
Shares out41.4M
Employees461
ListedFri, Jul 30, 2021
Free float37.79M
Float %91.9%
Short interest4.17M
Days to cover6.0d
Short volume68.6%
Squeeze score66 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.37 · 5 est
Last EPS vs est−$0.38 vs −$0.30
Last surprise-26.7% miss
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank15.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance7.01
Support4.52
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RXST

All disclosures →
No recent disclosed trades by Congress in RXST. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RXST · 10 buys

InsiderSideShares
Fountain Tamara
Director · Common Stock · 2026-06-17
Grant37.04K
LINK WILLIAM J PHD
Director · Common Stock · 2026-06-17
Grant37.04K
Corley Jesse Anderson
Director · Common Stock · 2026-06-17
Grant37.04K
Maniar Shweta
Director · Common Stock · 2026-06-17
Grant37.04K
PALMISANO ROBERT J
Director · Common Stock · 2026-06-17
Grant37.04K
Tammenoms Bakker Juliet
Director · Common Stock · 2026-06-17
Grant37.04K
Warner Robert Keith
Director · Common Stock · 2026-06-17
Grant37.04K
COHEN RAYMOND W
Director · Common Stock · 2026-06-17
Grant30.86K
Andrews Julie
Director · Common Stock · 2026-06-17
Grant37.04K
Goldshleger Ilya
Chief Operating Officer · Common Stock · 2026-04-17
Exercise12.49K

SEC filings

EDGAR filings in RXST · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.